ABVC Historical Cash Flow
| ABVC Stock | USD 3.35 0.23 6.42% |
Analysis of ABVC Biopharma cash flow over time is an excellent tool to project ABVC Biopharma future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Other Non Cash Items of 3.8 M or Capital Expenditures of 0.0 as it is a great indicator of ABVC Biopharma ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining ABVC Biopharma latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether ABVC Biopharma is a good buy for the upcoming year.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in ABVC Biopharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. About ABVC Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in ABVC balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which ABVC's non-liquid assets can be easily converted into cash.
ABVC Biopharma Cash Flow Chart
Add Fundamental
Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Most accounts from ABVC Biopharma's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into ABVC Biopharma current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in ABVC Biopharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. For information on how to trade ABVC Stock refer to our How to Trade ABVC Stock guide.At present, ABVC Biopharma's Other Non Cash Items is projected to increase significantly based on the last few years of reporting. The current year's Total Cash From Financing Activities is expected to grow to about 3.1 M, whereas Sale Purchase Of Stock is projected to grow to (7 K).
ABVC Biopharma cash flow statement Correlations
Click cells to compare fundamentals
ABVC Biopharma Account Relationship Matchups
High Positive Relationship
High Negative Relationship
ABVC Biopharma cash flow statement Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Free Cash Flow | (4.6M) | (7.6M) | (7.5M) | (4.3M) | (1.8M) | (1.9M) | |
| Change In Working Capital | (86.4K) | (1.6M) | 635.6K | 977.0K | (408.4K) | (388.0K) | |
| Other Cashflows From Financing Activities | (225.4K) | (946.2K) | (1.7M) | 2.4M | 1.9M | 2.0M | |
| Other Non Cash Items | 2.2M | (91.1K) | 353.0K | 3.5M | 3.7M | 3.8M | |
| Total Cash From Operating Activities | (4.6M) | (7.6M) | (7.4M) | (4.2M) | (1.8M) | (1.9M) | |
| Net Income | (10.6M) | (12.0M) | (16.3M) | (10.5M) | (5.3M) | (5.5M) | |
| Total Cash From Financing Activities | 9.6M | 10.0M | 4.0M | 3.9M | 2.0M | 3.1M | |
| End Period Cash Flow | 5.0M | 6.6M | 1.4M | 716.8K | 863.8K | 878.0K | |
| Change To Inventory | (88.2K) | (25.8K) | 26.0K | 68.5K | 78.8K | 82.7K | |
| Change In Cash | 4.8M | 1.6M | (5.2M) | (674.9K) | 147.0K | 154.4K | |
| Begin Period Cash Flow | 160.4K | 5.0M | 6.6M | 1.4M | 716.8K | 901.9K | |
| Total Cashflows From Investing Activities | (225.4K) | (806.0K) | (1.7M) | (360.2K) | (324.2K) | (340.4K) | |
| Depreciation | 37.1K | 12.0K | 23.8K | 28.5K | 200.9K | 211.0K | |
| Stock Based Compensation | 4.1M | 5.3M | 7.0M | 1.6M | 2.8M | 2.1M | |
| Other Cashflows From Investing Activities | 305.0 | (373.2K) | (788.5K) | (1.6M) | (1.4M) | (1.4M) | |
| Change To Account Receivables | 11.2K | (120.7K) | 3.7K | (121.0K) | (614.2K) | 228.6K | |
| Net Borrowings | 896.9K | 2.0M | 2.0M | (273.5K) | (314.5K) | (298.8K) | |
| Change To Operating Activities | 666.9K | (1.1M) | (1.4M) | 1.2M | 1.1M | 1.3M | |
| Change To Netincome | 2.6M | (145.5K) | 5.3M | 6.8M | 7.9M | 8.3M | |
| Issuance Of Capital Stock | 7.6M | 11.1M | 3.7M | 1.1M | 31.0K | 29.5K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether ABVC Biopharma offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of ABVC Biopharma's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Abvc Biopharma Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Abvc Biopharma Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in ABVC Biopharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. For information on how to trade ABVC Stock refer to our How to Trade ABVC Stock guide.You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ABVC Biopharma. If investors know ABVC will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ABVC Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.19) | Revenue Per Share | Quarterly Revenue Growth (0.09) | Return On Assets | Return On Equity |
The market value of ABVC Biopharma is measured differently than its book value, which is the value of ABVC that is recorded on the company's balance sheet. Investors also form their own opinion of ABVC Biopharma's value that differs from its market value or its book value, called intrinsic value, which is ABVC Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ABVC Biopharma's market value can be influenced by many factors that don't directly affect ABVC Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ABVC Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if ABVC Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ABVC Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.